News search

E.g., 25/06/2026
E.g., 25/06/2026
Rocío Sierra, Miguel Torres, Cristina Villa del Campo, Enrique Calvo, Jesús Vázquez y Consuelo Marín-Vicente.
Research
24 Jun 2026

Two CNIC teams have developed a pioneering technique to analyze proteins in individual cardiomyocytes and uncover new clues about cardiac regeneration

Florian Weinberg
About the CNIC
23 Jun 2026

CARDIOSWITCH aims to uncover how the mechanical activity of heart muscle cells shapes cardiac biology and to develop new regenerative strategies for congenital heart disease

About the CNIC
11 Jun 2026

The meeting forms part of European awareness-raising activities around the European Commission’s new strategy to strengthen prevention, early detection, and management of cardiovascular disease

Dr. Pablo García-Pavía junto con la Dra. Noelia Mora y la Dra. Belén Peiró
Research
21 Apr 2026

The biomarker MR-proADM improves risk prediction in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and is associated with greater disease severity, mortality, and heart failure events.

From left to right, Borja Ibáñez, Laura Cádiz, Agustín Clemente Moragón, Ángela Pollán, Lucía López Palomar, and Anabel Díaz Guerra.
Research
26 Feb 2026

The study shows that a simple, non-pharmacological technique known as remote ischemic conditioning (RIC) can protect the heart during treatment with anthracyclines

Ana Simón Chica y David Filgueiras Rama
Research
10 Feb 2026

The study, published in Circulation Research, identifies cardiac fibroblasts and resident macrophages as essential contributors to the characteristic electrical activity that maintains this arrhythmia

Foto
Research
5 Feb 2026

prespecified landmark analysis of the REBOOT trial, published in The European Heart Journal Cardiovascular Pharmacotherapy, shows no clinical benefit of beta-blockers during the first year after infarction or beyond one year, in patients without reduced ejection fraction.

Equipo del CNIC
Research
2 Feb 2026

A team from the CNIC and Hospital Clínico Universitario de Valladolid has developed a minimally invasive, catheter-based procedure to treat defective mechanical aortic valves

Research
14 Jan 2026

A CNIC research team has identified for the first time the biological mechanism underlying this susceptibility: high blood pressure creates a hidden metabolic vulnerability in the heart that becomes destabilized when anthracyclines are administered.